YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Jubilant Pharmo
Jubilant Pharmo
BSE: 530019NSE: JUBLPHARMAISIN: INE700A01033

7th-May-2021 17:04Source: BSE

Jubilant Pharmova - Announcement under Regulation 30 (LODR)-Credit Rating

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that CRISIL Ratings has removed Long Term Bank Facilities and Non-Convertible Debentures of the Company from ''Rating Watch with Developing Implications'' and has assigned a 'Positive' outlook for the long-term rating. CRISIL Ratings has also withdrawn the rating on the bank facilities on receipt of a ''No Objection Certificate' from the banker and on debt instruments of the Company, as the bank facilities and debt instruments have been transferred to Jubilant Ingrevia Limited, post demerger of the Life Science Ingredients Business of the Company. The rating withdrawal is based on the Company's request and in line with CRISIL Rating's policy on withdrawal of ratings. The instrument-wise ratings are given in the attached letter.

More Announcements on:

Sections